MA35239B1 - Fgfr1 agonists and their methods of use - Google Patents

Fgfr1 agonists and their methods of use

Info

Publication number
MA35239B1
MA35239B1 MA36524A MA36524A MA35239B1 MA 35239 B1 MA35239 B1 MA 35239B1 MA 36524 A MA36524 A MA 36524A MA 36524 A MA36524 A MA 36524A MA 35239 B1 MA35239 B1 MA 35239B1
Authority
MA
Morocco
Prior art keywords
methods
fgfr1
agonists
fgfr1 agonists
relates
Prior art date
Application number
MA36524A
Other languages
French (fr)
Inventor
Yan Wu
Junichiro Sonoda
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/037964 external-priority patent/WO2012158704A1/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA35239B1 publication Critical patent/MA35239B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention porte sur des agonistes de fgfr1, dont des anticorps anti-fgfr1 agonistes, et sur leurs procédés d'utilisation.The invention relates to fgfr1 agonists, including anti-fgfr1 agonist antibodies, and methods of their use.

MA36524A 2011-05-16 2013-12-04 Fgfr1 agonists and their methods of use MA35239B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161486731P 2011-05-16 2011-05-16
PCT/US2012/037964 WO2012158704A1 (en) 2011-05-16 2012-05-15 Fgfr1 agonists and methods of use

Publications (1)

Publication Number Publication Date
MA35239B1 true MA35239B1 (en) 2014-07-03

Family

ID=51581879

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36524A MA35239B1 (en) 2011-05-16 2013-12-04 Fgfr1 agonists and their methods of use

Country Status (1)

Country Link
MA (1) MA35239B1 (en)

Similar Documents

Publication Publication Date Title
CY1119098T1 (en) FGFR1 AGONERS AND METHODS OF USE
MA38632B1 (en) Anti-transferrin receptor antibodies and methods of use
MA37538A2 (en) Anti-Ly6 antibodies and immunoconjugates and methods of use
MA35712B1 (en) Anti-htra1 antibodies and methods of use
EP2582729A4 (en) ANTI-AXL ANTIBODIES, AND METHODS OF USE.
MA34818B1 (en) ANTI-PCSK9 ANTIBODIES AND METHODS OF USE
EA201390933A1 (en) ANTIBODIES AGAINST MEZOTELINE AND IMMUNOCONJUGATES
MA40682B1 (en) Anti-ox40 antibodies and methods of use thereof
MX2013011479A (en) Anti-fgfr4 antibodies and methods of use.
CR20140441A (en) ANTI-LGR5 AND IMMUNOCATE PLAYERS
NZ604510A (en) Dilutable biocidal compositions and methods of use
MA39095A1 (en) Anti-cd33 antibodies and immunoconjugates
EP2702141A4 (en) METHODS AND SYSTEM FOR INTERVENING ON THE VIABILITY OF BACTERIA, AND COMPOUNDS AND COMPOSITIONS RELATED THERETO
MA35898B1 (en) Anti-lrp5 Antibodies and Methods of Use
MX2013001473A (en) Antibodies against il-18r1 and uses thereof.
EA201390660A1 (en) MODIFIED NICOTINE COMPOUNDS AND RELATED METHODS
MX336323B (en) Anti-polyubiquitin antibodies and methods of use.
MX354303B (en) Anti-biotin antibodies and methods of use.
EP2582799A4 (en) BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF (S) -3- (1-AMINOETHYL) -PHENOL
ECSP11011190A (en) ANTI-RHD MONOCLONAL ANTIBODIES
BR112015003032A2 (en) anti-jagged antibodies and methods of use '.
MX2014014381A (en) Anti-theophylline antibodies and methods of use.
MA35239B1 (en) Fgfr1 agonists and their methods of use
MA39355A1 (en) Anti-ox40 antibodies and methods of use thereof
MA35947B1 (en) Anti-lgr5 antibodies and immunoconjugates